Neo Medical’s ADVISE platform is designed to address the full-breadth of spine surgery, from equipment to support during surgery. Image credit: PeopleImages.com – Yuri A via Shutterstock.

Neo Medical的ADVISE平台旨在涵盖脊柱手术的全部范围，从设备到手术期间的支持。图片来源：PeopleImages.com – Yuri A 通过 Shutterstock。

A new study has demonstrated the value of Neo Medical’s Force Control technology and pedicle screws in thoracolumbar fusion spine surgery.

一项新的研究证明了Neo Medical的力控制技术和椎弓根螺钉在胸腰椎融合脊柱手术中的价值。

Published in the April edition of

发布于四月版

World Neurosurgery

世界神经外科

, the study demonstrated that through a combination of the Swiss company’s Force Control technology and pedicle screws, early screw loosening was mitigated and patient outcomes improved due to the management of unintended mechanical stress in surgery.

，该研究表明，通过结合瑞士公司的力控制技术和椎弓根螺钉，减轻了早期螺钉松动的问题，并且由于对手术中非预期的机械应力进行了管理，患者预后得到了改善。

According to Neo Medical, Force Control limits the unintended stress applied to both implants and surrounding anatomical structures as fusion spine surgeries, which often involve joining and ‘screwing down’ two or more vertebrae in the spine, are undertaken.

根据Neo Medical的说法，力控制限制了在进行融合脊柱手术时对植入物和周围解剖结构施加的非预期应力，这种手术通常涉及连接和“固定”脊柱中的两个或多个椎骨。

Co-led by David Noriega, chief of the orthopaedic department at Spain’s Clínico Universitario de Valladolid hospital; and Dr Yasser Abdalla, head of neurosurgery at Germany’s Northwest Sanderbusch hospital, the clinical study assessed 75 patients undergoing thoracolumbar fusion surgery for conditions such as spinal stenosis and degenerative disc disease..

由西班牙瓦拉多利德大学医院骨科主任大卫·诺里加和德国西北桑德布施医院神经外科主任亚瑟·阿卜杜拉共同领导的临床研究，评估了75名因脊柱狭窄和退行性椎间盘疾病等病症接受胸腰椎融合手术的患者。

Neo’s pedicle screws, as facilitated by the company’s Force Control technology, resulted in a screw loosening rate of 2.7% versus 9.2% seen in the control group at the one-year follow-up.

在一年的随访中，借助公司力控制技术的Neo椎弓根螺钉的松动率为2.7%，而对照组为9.2%。

In addition, patient disability scores as measured by the Oswestry Disability Index were 38% lower after one year with the use of Neo’s solutions as compared with the control group.

此外，使用Neo的解决方案一年后，患者的残疾评分（通过Oswestry残疾指数测量）比对照组低38%。

At the two-year follow-up, implant-related revision rates in the Neo group were 4.1%, indicative of a 58% reduction versus the control group at 9.8%.

两年随访时，Neo组的植入物相关翻修率为4.1%，相比对照组的9.8%，降低了58%。

Dr Abdalla commented: “These results highlight how Neo’s Force Control technology allows us to apply corrective forces effectively while minimising harmful mechanical stress.

阿卜杜拉博士评论道：“这些结果突显了Neo的力控制技术如何使我们能够在有效施加矫正力的同时，尽量减少有害的机械应力。

“By protecting both the implants and the patient’s anatomy, we can reduce complications and achieve better outcomes in spinal fusion surgery.”

“通过保护植入物和患者的解剖结构，我们可以减少并发症，并在脊柱融合手术中取得更好的效果。”

According to Neo Medical’s co-founder and co-CEO Vincent Lefauconnier, the results highlight the technology’s benefit in reducing some of the most common and damaging complications that “too often limit” the benefits patients see after surgery.

根据Neo Medical的联合创始人兼首席执行官文森特·勒福康尼尔的说法，结果突显了该技术在减少一些最常见且最具破坏性的并发症方面的益处，这些并发症“经常限制”患者术后所能看到的好处。

Last year, Neo

去年，Neo

raised $68m

筹集了6800万美元

in a Series B funding round to expand its surgical technology platform across the US. Force Control and the Lausanne-headquartered company’s related pedicle screws for spine surgery are part of its broader ADVISE platform, which also includes AI and augmented reality (AR)-based tools that aim to improve spine surgery procedures..

在B轮融资中，该公司计划将其手术技术平台扩展到美国各地。力控制技术以及总部位于洛桑的公司相关的脊柱手术用椎弓根螺钉是其更广泛的ADVISE平台的一部分，该平台还包括基于人工智能和增强现实（AR）的工具，旨在改进脊柱手术程序。

Sign up for our daily news round-up!

注册获取我们的每日新闻汇总！

Give your business an edge with our leading industry insights.

通过我们领先的行业洞察，为您的业务提供优势。

Sign up

注册

Share

分享

Copy Link

复制链接

Share on X

分享到X

Share on Linkedin

分享到领英

Share on Facebook

分享到 Facebook